Lowe Lintas has been appointed as the brand and communications partner for Cofsils, part of the Cipla Health portfolio, following a competitive multi-agency pitch. The win grants the agency an integrated mandate across the full Cofsils product range, which includes throat lozenges, cough drops, and cough syrup.
The scope of Lowe Lintas’ role spans comprehensive brand strategy, creative development, digital-first storytelling, and healthcare professional (HCP) communication. This partnership aims to revitalize the Cofsils brand and strengthen its presence in a highly competitive market.
Shivam Puri, managing director and CEO of Cipla Health, praised Lowe Lintas for its strategic insight and creative approach, stating, “Their deep consumer empathy and thoughtful storytelling gave them the edge. We believe they are well-equipped to drive Cofsils’ next phase of growth.”
Subramanyeswar S, group CEO – India and CSO – APAC at MullenLowe Global, emphasized the significance of the renewed trust, saying, “It’s an honor to further our relationship with Cipla Health as we work together toward a healthier future.”
Anaheeta Goenka, COO at Lowe Lintas, expressed excitement about the win, noting the challenge and opportunity it presents. “Cofsils is a challenger brand in a crowded space. Winning this mandate means reigniting consumer interest and shifting preferences, which will demand the best of our strategic and creative capabilities.”
The collaboration marks a significant step for both Cofsils and Lowe Lintas as they aim to elevate the brand’s visibility and connect more deeply with consumers.
